provides the most effective method of ensuring product security

Size: px
Start display at page:

Download "provides the most effective method of ensuring product security"

Transcription

1 28 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 Supports anti-counterfeiting and public health Combats fraud and prevents reimbursement fraud Reduces dispensing errors Gives quality assurance for patients Provides common standards across Europe, allowing inter-operability Offers a cost-effective solution for all parties provides the most effective method of ensuring product security 29 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

2 Traceability enabling technologies Technology epedigree Serialization Authentication RFID Datamatrix or barcode Fast and reliable printing In-line printing controls Invisible taggant Optical Variable Devices DNA- or chemicalbased security tag 31 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 A Univoque and NON-Predictive series of Characters has to be printed on the BOX at the manufacturing site, and verified at the subministration &/or sales point A safe connection to a Unique reference Database verify the correlation between the two numbers, so can authenticate each single box The Pharmacist can check the AUTHENTICITY of each single box connecting the Vendor s DB Manufacturer Distribution Chain Pharmacy Carton 1234 Carton Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 A Univoque and NON-Predictive series of Characters has to be printed on the BOX at the manufacturing site, with a second code in addition (possibly hidden), or any additional safe measure (special inks, etc.) The additional element is not verified at the distribution or at the sales point, but it s used by the vendor or by the distributor as an additional Autenticity confirmation Manufacturer Distribution Chain Pharmacy Carton 1234 Covert Code ABC Carton 1234 Covert Code ABC 33 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

3 Univoque and NON-Predictive series of Characters printed at each Packaging Line The code are related eachother either with specific Generation Procedures and/or either some aggregation/grouping procedures during Production Even if this solution has some validity inside the plant, it could even use by authentication Process by the Pharmacist Manufacturer Carton 1234 Case ABCD Pallet K6J7 Codes are related eachother 34 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 A Unique Code identify the smallest unit of the product, and will be RECORDED at any steps of the supply chain to the distribution/sales point The ELECTRONIC PEDEGREE allows each supply chain component to trace all steps to the manufaturing plant This solution could be implemented together with other Grouping or Identification Tecniques Manufacturer Wholesaler A Wholesaler B Pharmacy Shipment JHKL Shipment JHKL Shipment JHKL Shipment JHKL 35 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev Worldwide Initiatives (Analysis Coding & tecniques Recommandations by EFPIA, epedegree, Brazilian Resolution) 36 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

4 GS1 is a leading global not-for-profit organisation dedicated to the design and implementation of global standards and solutions to improve the efficiency and visibility of supply and demand chains globally and across sectors Formed in 2005 out of the EAN International and the UCC organizations) The GS1 system of standards is the most widely used supply chain standards system in the world GS1's products and solutions are used across a wide range of industry sectors 37 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 EPCglobal is a joint venture between GS1 (formerly known as EAN International) and GS1 US (formerly the Uniform Code Council) It is an organization set up to achieve worldwide adoption and standardization of Electronic Product Code (EPC) technology The main focus of the group currently is to create both a worldwide standard for RFID and the use of the Internet to share data via the EPC Global Network EPCglobal's board of governors includes representatives from EPCglobal, GS1, Auto-ID Labs, Cisco Systems, DHL/Exel Supply Chain, Haier Group Company, Johnson & Johnson, Kimberly-Clark Corporation, LG Electronics, Lockheed Martin Corporation, METRO AG, Novartis Pharma AG, Office of the Secretary of Defense, Procter & Gamble, Sony Corporation, The Dow Chemical Company and Wal-Mart Stores, Inc. 38 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 EFPIA: European Federation of Pharmaceutical Industries and Associations Represents the pharmaceutical industry operating in Europe. Through its direct membership of 31 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 2,200 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. 39 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

5 The European Commission is proposing a number of legislative actions to address the problem of the increase of medicinal products detected in the EU which are falsified in relation to their identity, history or source. While broadly speaking EFPIA welcomes the Commission's initiative to propose concrete measures to address these problems, EFPIA does not believe that patient safety would be fully secured through the Commission s current proposals. Efpia Position Paper on European Commission s on Counterfeit Madicinal Products (October, 2009) 40 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

6 43 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 Serialization is the process of identifying an object with a unique serial number that can be exchanged universally In the pharmaceutical industry is applied to each item, case, and pallet of a drug to track the flow of product within the supply chains of manufacturers, distributors and wholesalers Pharmaceutical companies that implemented epedigree solutions are now looking at implementing serialization using 2D barcode and RFID technology to transfer product information between trading partners towards gaining compliance 45 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

7 46 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 One cell quiet zone surrounds the matrix Clock pattern off on sequence This cell is always white for ECC200 Clock pattern off on pattern L shape locator pattern Cell size is important inches/0.33mm seems to give best read rates- and is GS-1 recommended 47 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 A Data Matrix code is a two-dimensional matrix barcode consisting of black and white "cells" or modules arranged in either a square or rectangular pattern The information to be encoded can be text or raw data Usual data size is from a few bytes up to 2 kilobytes The length of the encoded data depends on the symbol dimension used Error correction codes are added to increase symbol strength: even if they are partially damaged, they can still be read A Data Matrix symbol can store up to 2,335 alphanumeric characters Data Matrix symbols are rectangular in shape and usually square, they are made of cells: little elements that represent bits Depending on the situation a "light" module is a 0 and a "dark" module is a 1, or vice versa. Every Data Matrix is composed of two solid adjacent borders in an "L" shape (called the "finder pattern") and two other borders consisting of alternating dark and light "cells" or modules (called the "timing pattern"). Within these borders are rows and columns of cells encoding information. The finder pattern is used to locate and orient the symbol while the timing pattern provides a count of the number of rows and columns in the symbol. As more data is encoded in the symbol, the number of cells (rows and columns) will increase. Symbol sizes vary from 8 8 to Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

8 Compared to other barcode types, Data Matrix is approximately 30 times smaller than a Code 39 barcode representing the same data The required Reed-Solomon error correction built into Data Matrix ECC200 is able to reconstruct and verify the data scanned for improved accuracy Linear and 2D Barcode Simbology Evaluation Chart Code 39 without check digit: Code 128 Auto: Data Matrix ECC200 with ASCII encoding mode: Barcode Type Worst Case Accuracy Best Case Accuracy Data Matrix 1 error in 10.5 million 1 error in million Code error in 2.8 million 1 error in 37 million Code 39 1 error in 1.7 million 1 error in 4.5 million 49 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 A pedigree is a document that contains prescription drug information and chain of custody as it moves through the supply chain An epedigree is an electronic record of drug information and drug chain of custody that is authenticated and updated electronically as drugs move through the supply chain Trading partners - exchange epedigrees and have the ability to update them working with common standards (GS1 which provides standards for manufacturers, distributors, wholesalers and retailers for epedigree information epedigree - records with complete and accurate information about each transaction during transfer of ownership, lot number, dosage and expiration date of the drugs, company details (name, address, and license number) 50 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

9 52 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 Europe Safe & Secure Supply Chain US (e) - Pedigree ID Verify Physical Verification Track Proactive Track Retrospective Product Security Transactio n Security 54 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

10 55 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 COUNTRY IMPLEMENTATION DEADLINE Australia Current (2007) Belgium Current Brazil 1/14/2012 Canada Current (2008) Chile 2010 China Current France 12/31/2010 Germany 2009 COUNTRY IMPLEMENTATION DEADLINE Greece Current (2005) Ireland Italy Current Current Japan 2009 Korea 2013 New Zealand 2009 Turkey 07/01/2009 Serialization Implementation dates for various countries (As of March 2009) 56 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 EFPIA in collaboration with Apoteket AB conducted a pilot project in order to demonstrate the feasibility of the proposed approach to product verification The pilot was carried out in Sweden during the period of 17 September 2009 to 25 January 2010 in cooperation with the Swedish pharmaceutical manufacturers association ( Läkemedelsindustriföreningen, Lif). 1. Amgen 2. Astra-Zeneca 3. Bayer HealthCare 4. Boehringer Ingelheim 5. GlaxoSmithKline 6. Janssen Cilag 7. Lundbeck 8. Merck Serono 9. Novartis 10. Novo Nordisk 11. Nycomed 12. Pfizer 13. Roche 14. Sanofi Aventis Apoteket selected 25 pharmacies in the greater Stockholm area to participate in the project. The total number of dispensing points in the selected pharmacies is about 180 while the number of dispensing points per pharmacy ranges from 2 to 10. Fourteen pharmaceutical companies provided a total of 25 products for participation in the pilot. It was the goal of EFPIA to have about 100,000 packs verified and dispensed during the duration of the operational phase of the pilot. All participating pharmacies were equipped with scanners capable of reading Data Matrix codes to allow for product verification. Also, the existing Point of Sale (POS) was amended to include the necessary extra functionality. Product verification and dispense operations were fully integrated into the ordinary pharmacy workflow. 57 Buenos Aires ETIF International and ANVISA Traceability Requirements G. Rossi 2010 rev

3. Available Models General Overview on Existing Identification Tecniques & Models

3. Available Models General Overview on Existing Identification Tecniques & Models 3. Available Models General Overview on Existing Identification Tecniques & Models 1 Universidad de Belgrano Medicine Traceability Overview 18 Majo, 2010 2 Universidad de Belgrano Medicine Traceability

More information

Supply chain integrity Fighting counterfeiting in healthcare

Supply chain integrity Fighting counterfeiting in healthcare Supply chain integrity Fighting counterfeiting in healthcare The increasing, global threat of counterfeiting in healthcare What is the problem? Counterfeit drugs may harm the patient. Often impossible

More information

Verification of Pharmaceutical Products at the Point of Dispense. Status of the EFPIA Project

Verification of Pharmaceutical Products at the Point of Dispense. Status of the EFPIA Project Verification of Pharmaceutical Products at the Point of Dispense Speaker : Grant Courtney Status of the EFPIA Project Event: GS1 Global Forum - São Paulo 1 Who is EFPIA? The European Federation of Pharmaceutical

More information

International and ANVISA Traceability Requirements

International and ANVISA Traceability Requirements International and ANVISA Traceability Requirements 1 Buenos Aires ETIF 2010 - International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 1. Supply Chain Issues 2. COUNTERFEITING 3. Worldwide

More information

Medicine Traceability & AUthenticity

Medicine Traceability & AUthenticity Medicine Traceability & AUthenticity Overview Universidad de Belgrano 18 Mayo, 2010 1 Universidad de Belgrano Medicine Traceability Overview 18 Mayo, 2010 1. A Glance on CTP 2. Introduction 3. Good and

More information

Global Serialisation Developments and the Need for Convergence. Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015

Global Serialisation Developments and the Need for Convergence. Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015 Global Developments and the Need for Convergence Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015 Developments across the world Regulatory bodies need to address Public Health issues one

More information

What makes a successful application?

What makes a successful application? Printing technologies for Data Matrix Codes Lee Metters December 2007 What makes a successful application? Data Preparation Appropriate for type of application Printer Print accuracy Print speed Consistency

More information

Pharmaceutical Serialization in Brasil. 12 Mar 2015

Pharmaceutical Serialization in Brasil. 12 Mar 2015 Pharmaceutical Serialization in Brasil 12 Mar 2015 Agenda Introduction Serialization Supply Chain Overview Global Regulatory Snapshot Discussion and Comparison of RDC No. 54 (Brasil Law) Key Impact Considerations

More information

GS1 Ireland Healthcare User Group (HUG) Information Day

GS1 Ireland Healthcare User Group (HUG) Information Day GS1 Ireland Healthcare User Group (HUG) Information Day Overview on EU FMD regulation and unique identification requirements Geraldine Lissalde-Bonnet, GS1 Global Office 28 th March 2017 Overview on EU

More information

EFPIA Product Verification Project

EFPIA Product Verification Project EFPIA Product Verification Project Joint Final Report April 2010 EFPIA/Apoteket AB - 06 April 2010 Original document authors: Anthony Barron, EFPIA Birgitta Lange-Sjöblom, Apoteket AB Lars Rönnbäck, Apoteket

More information

Health Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain

Health Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain 1 Health Care/Pharmaceutical GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain 2 Health Care/Pharmaceutical: GS1 Standards for Serialization and Visibility Within

More information

Verification of Pharmaceutical Products at the Point of Dispense. An EFPIA update

Verification of Pharmaceutical Products at the Point of Dispense. An EFPIA update Verification of Pharmaceutical Products at the Point of Dispense Speaker : Grant Courtney Event: GS1 Global Conference Location: Washington An EFPIA update 1 Who is EFPIA? The European Federation of Pharmaceutical

More information

Pfizer s Pedigree & RFID Pilots An Overview

Pfizer s Pedigree & RFID Pilots An Overview An Overview Granada, February 2008 Tim Marsh Senior Manager Pfizer V-Tag C-Tag Pedigree Pilots Ongoing Work and Collaboration V-Tag Viagra RFID Pilot Mass Serialization at Item, Case and Pallet Level via

More information

Serialization and epedigree: New Opportunities for Life Sciences Manufacturers

Serialization and epedigree: New Opportunities for Life Sciences Manufacturers Serialization and epedigree: New Opportunities for Life Sciences Manufacturers Table of Contents Serialization and epedigree: Current Direction... 3 Why Invest in Serialization?... 3 What Tasks do Life

More information

Agenda. The Past: 1990 s. Healthcare. Supply Efficiencies Pallet Through Retail Packages The Present:

Agenda. The Past: 1990 s. Healthcare. Supply Efficiencies Pallet Through Retail Packages The Present: Agenda The Past: 1990 s Supply Efficiencies Pallet Through Retail Packages The Present: 2000-2005 Prevention of Dispensing Errors Unit Dose and Unit of Use Packages The Future: 2005 Forward Counterfeit

More information

European Union (EU) Falsified Medicines Directive

European Union (EU) Falsified Medicines Directive European Union (EU) Falsified Medicines Directive Mr. Mike Rose, Vice President, Supply Chain Visibility Johnson & Johnson 18 October 2017 GS1 2017 The Promise of Serialization EU Falsified Medicines Directive

More information

Pharmaceutical RFID: From Mandates to Endorsements and Laws

Pharmaceutical RFID: From Mandates to Endorsements and Laws Pharmaceutical RFID: From Mandates to Endorsements and Laws By Sara Shah, Industry Analyst, RFID and M2M Research, ABI Research The healthcare industry s motivation for adopting RFID can be attributed

More information

Experience with Serialization Implementation as one powerful measure to protect our patients. Françoise Hirth

Experience with Serialization Implementation as one powerful measure to protect our patients. Françoise Hirth Experience with Serialization Implementation as one powerful measure to protect our patients Françoise Hirth Objectives 1 2 3 Supply Chain integrity & product security A worldwide concern Pharma Industry

More information

Serialization Primer

Serialization Primer Serialization Primer Introduction Global pharmaceutical distribution networks and supply chains have become more complex and interconnected, quickening the pace of regulations that mandate pharmaceutical

More information

GS1 standards for unique identification of medicinal products

GS1 standards for unique identification of medicinal products GS1 standards for unique identification of medicinal products Lisbon, Portugal 3 July 2013 Silverio Paixão, Chief Innovation & Standards Officier, GS1 Portugal Who is GS1? GS1 a neutral, not-for-profit,

More information

Saudi Drug Code (SDC), and Drug Barcoding Specifications

Saudi Drug Code (SDC), and Drug Barcoding Specifications Drug Sector Licensing Executive Directorate Guidance for Industry Saudi Drug Code (SDC), and Drug Barcoding Specifications This document outlines the SDC and the new drug barcode requirements for pharmaceuticals.

More information

The Global Language of Business. Guide to Encode the Unique Identifier on Medicinal Products

The Global Language of Business. Guide to Encode the Unique Identifier on Medicinal Products The Global Language of Business Guide to Encode the Unique Identifier on Medicinal Products Introduction The Directive 2011/62/EU Falsified Medicines Directive aims to establish the safety features necessary

More information

Serialization a global approach. Emanuele Tellaroli Key Account Manager ANTARES VISION

Serialization a global approach. Emanuele Tellaroli Key Account Manager ANTARES VISION Serialization a global approach Emanuele Tellaroli Key Account Manager ANTARES VISION Beirut 02 June 2016 Serialization concept THE SMALLEST ITEM PUT ON SALE (selling unit) IS IDENTIFIED BY THE COMBINATION

More information

COUNTERFEIT MEDICINES IMPACT AND POTENTIAL SOLUTIONS

COUNTERFEIT MEDICINES IMPACT AND POTENTIAL SOLUTIONS COUNTERFEIT MEDICINES IMPACT AND POTENTIAL SOLUTIONS October 2-3, 2012 The World Bank Innovative technologies to identify fake and substandard drugs in resource-limited settings: Supply chain related technologies

More information

Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE

Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE 1 GS1 STANDARDS IN HEALTHCARE Together, we re making it possible to follow drugs and medical devices from the manufacturer

More information

Background to the Falsified Medicines Directive and the Delegated Regulation. Susan Grieve, Principal Pharmacist, Department of Health 12 April 2016

Background to the Falsified Medicines Directive and the Delegated Regulation. Susan Grieve, Principal Pharmacist, Department of Health 12 April 2016 Background to the Falsified Medicines Directive and the Delegated Regulation Susan Grieve, Principal Pharmacist, Department of Health 12 April 2016 Background to the Falsified Medicines Directive and the

More information

global standards infrastructure Chris Adcock

global standards infrastructure Chris Adcock EPCglobal - developing the global standards infrastructure Chris Adcock President, EPCglobal Inc. Agenda About EPCglobal Why are standards important The EPCglobal Network EPCIS EPC information Services

More information

AIDC Application Standards for Healthcare

AIDC Application Standards for Healthcare AIDC Application Standards for Healthcare GS1 DataMatrix Chuck Biss GS1 Global Office Topics A General Discussion of GS1 DataMatrix, with a GS1 Healthcare Application Standards Focus Why GS1 DataMatrix

More information

A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland)

A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland) Impressions Kaiseraugst A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland) SETRM2016 Rastreabilidade de Medicamento Sao Paulo, Jun 2016 Agenda Worldwide,

More information

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

1201 Maryland Avenue SW, Suite 900, Washington, DC , 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org April 16, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,

More information

Along with this the interesting aspects of varied solutions different countries and continents are exploring.

Along with this the interesting aspects of varied solutions different countries and continents are exploring. The past months, have been fascinating for those of us watching developments in the drive to increase security in the food and pharmaceutical industry. Along with this the interesting aspects of varied

More information

A guide to barcode symbology for the logistics industry

A guide to barcode symbology for the logistics industry A guide to barcode symbology for the logistics industry Symbology in barcodes Barcode technologies provide fast reliable data collection to ensure item or package traceability, and enhance customer service.

More information

Marking Pharmaceuticals & Medical Devices for the 2012 GTIN Sunrise EXPECTATIONS FOR 2012 AND BEYOND

Marking Pharmaceuticals & Medical Devices for the 2012 GTIN Sunrise EXPECTATIONS FOR 2012 AND BEYOND Marking Pharmaceuticals & Medical Devices for the 2012 GTIN Sunrise EXPECTATIONS FOR 2012 AND BEYOND Contents EXECUTIVE OVERVIEW... 4 DOCUMENT INFORMATION... 5 PURPOSE... 5 AUDIENCE... 5 SCOPE... 5 2012

More information

Implementation Reality - Traceability

Implementation Reality - Traceability Implementation Reality - Traceability GS1 Healthcare Global Conference San Francisco, California, USA Wednesday 2 nd October 2013 Agenda Introduction Case Studies Janice Kite, GS1 Global Office Manufacturer

More information

Regulatory Update: The US Drug Supply Chain Security Act (DSCSA) December 2017

Regulatory Update: The US Drug Supply Chain Security Act (DSCSA) December 2017 Regulatory Update: The US Drug Supply Chain Security Act (DSCSA) December 2017 Regulatory Agency Regulation Name or System Name Compliance Dates U.S. Department of Health and Human Services (HHS), Food

More information

Supply Chain Visibility and the EPCglobal Network

Supply Chain Visibility and the EPCglobal Network Supply Chain Visibility and the EPCglobal Network Nicholas Fergusson EPCglobal Inc. 13 th April 2005 Creation of EPCglobal Auto ID Center Founded 1999 6 Labs and 100 sponsoring companies RF principles

More information

FDA, Counterfeit, and RFID Technology

FDA, Counterfeit, and RFID Technology FDA, Counterfeit, and RFID Technology Edmund W. Schuster APICS members should note the implications of an article that appeared in the Wall Street Journal on February 19, 2004. Among other things, the

More information

Mass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland

Mass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland Mass Serialization and Traceability Implementation in the Pharma Industry Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland What drives the industry towards more traceability Strategic

More information

EPCglobal Update. Academic Alliance, MIT, Boston Bernie Hogan 23 January 2006

EPCglobal Update. Academic Alliance, MIT, Boston Bernie Hogan 23 January 2006 EPCglobal Update Academic Alliance, MIT, Boston Bernie Hogan 23 January 2006 A look into the past. Evolution to EPCglobal From New Technology to Business Standards Auto-ID Center Auto-ID Inc. 2004 and

More information

Discussion paper on recent developments of the Russian system of goods labelling with identification means

Discussion paper on recent developments of the Russian system of goods labelling with identification means Purpose The purpose of this paper is to facilitate the discussions about the establishment of a globally harmonised system for traceability of pharmaceuticals withinrussia, but also between Russia and

More information

RFID supply chain standards. Brussels, 24 October 2007 Henri Barthel, GS1 Global Office

RFID supply chain standards. Brussels, 24 October 2007 Henri Barthel, GS1 Global Office RFID supply chain standards Brussels, 24 October 2007 Henri Barthel, GS1 Global Office GS1 in a nutshell GS1 is a not-for-profit organisation that develops global standards for the identification of goods

More information

What To Do or Not To Do? Utility of Medication Traceability to the Patient

What To Do or Not To Do? Utility of Medication Traceability to the Patient What To Do or Not To Do? Utility of Medication Traceability to the Patient Melsen Kwong, Pharm.D. Associate Director Department of Pharmacy Services Cedars-Sinai Medical Center, Los Angeles, CA, USA Objectives

More information

Medicines Barcoding and Serialization Guideline. National Health Regulatory Authority (NHRA) Kingdom of Bahrain

Medicines Barcoding and Serialization Guideline. National Health Regulatory Authority (NHRA) Kingdom of Bahrain edicines Barcoding and Serialization Guideline National Health Regulatory Authority (NHRA) Kingdom of Bahrain August 2018 Version 1.0 Chief of Pharmaceutical Product Regulation: Dr / Roaya Al Abbasi Date:

More information

Healthcare. Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA

Healthcare. Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA Healthcare Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA Release 1.0, May 23 2017 Table of Contents 1 Introduction... 7 2 IDENTIFY: Questions about GS1

More information

EXISTING TECHNOLOGIES AND TRACK AND TRACE MODELS IN USE AND TO BE DEVELOPED BY MEMBER STATES. TABLE: EXPERIENCES IN COUNTRIES (updated November 2017)

EXISTING TECHNOLOGIES AND TRACK AND TRACE MODELS IN USE AND TO BE DEVELOPED BY MEMBER STATES. TABLE: EXPERIENCES IN COUNTRIES (updated November 2017) EXISTING TECHNOLOGIES AND TRACK AND TRACE MODELS IN USE AND TO BE DEVELOPED BY MEMBER STATES TABLE: EXPERIENCES IN COUNTRIES (updated November 2017) In November 2017, the Table: Experiences in Countries

More information

Implementation Reality Traceability

Implementation Reality Traceability Implementation Reality Traceability How to enable/implement traceability? 2 nd April 2014, Seoul/Korea Round 1 (13:30 15:00) Moderator Grant Courtney, Business Lead, Fingerprint Serialisation, Global Manufacturing

More information

The European Stakeholder Model A Medicines Verification System for Europe (ESM)

The European Stakeholder Model A Medicines Verification System for Europe (ESM) The A Medicines Verification System for Europe (ESM) Fighting g counterfeit medicines to ensure patient safety in Europe Martin Friedrich, i Andreas Walter ESM Stakeholders 2013-07-03 European Medicines

More information

Counterfeit Drugs and Supply Chain Security

Counterfeit Drugs and Supply Chain Security Counterfeit Drugs and Supply Chain Security Rick Mitzner Senior Director, Engineering Technology Pfizer, Inc. Interphex April 21, 2015 Tragic Consequences Not If But When and Where May 7, 2007 80 children

More information

Response to: PUBLIC CONSULTATION IN PREPARATION OF A LEGAL PROPOSAL TO COMBAT COUNTERFEIT MEDICINES FOR HUMAN USE

Response to: PUBLIC CONSULTATION IN PREPARATION OF A LEGAL PROPOSAL TO COMBAT COUNTERFEIT MEDICINES FOR HUMAN USE Response to: PUBLIC CONSULTATION IN PREPARATION OF A LEGAL PROPOSAL TO COMBAT COUNTERFEIT MEDICINES FOR HUMAN USE EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE GENERAL CONSUMER GOODS, PHARMACEUTICALS

More information

ASK THE EXPERTS GS1 DataMatrix

ASK THE EXPERTS GS1 DataMatrix ASK THE EXPERTS GS1 DataMatrix The Basics and an Example Implementation GS1 Healthcare Conference Budapest 21 October 2015 Ask the Experts GS1 DataMatrix Today s presenters GS1 DataMatrix The Basics -

More information

Inside EU FMD and the Delegated Acts A Compliance Primer

Inside EU FMD and the Delegated Acts A Compliance Primer Inside EU FMD and the Delegated Acts A Compliance Primer TABLE OF CONTENTS 01 02 03 04 05 06 EU FMD And Delegated Acts Requirements How Is EU FMD Governed? What Are The Roles For Different Supply Chain

More information

The world of GS1 standards in healthcare. Chris Adcock GS1 Global Office

The world of GS1 standards in healthcare. Chris Adcock GS1 Global Office The world of GS1 standards in healthcare Chris Adcock GS1 Global Office Topics Background Where we are going Where we are today What this means to you Questions Background Topics Where we are going Where

More information

STRATEGIES FOR DRUG ANTI-COUNTERFEITING IN GLOBAL SUPPLY CHAIN

STRATEGIES FOR DRUG ANTI-COUNTERFEITING IN GLOBAL SUPPLY CHAIN STRATEGIES FOR DRUG ANTI-COUNTERFEITING IN GLOBAL SUPPLY CHAIN 1 EXECUTIVE SUMMARY Emerging markets are expected to contribute a major share of the growth percentage in global pharma business. Plans have

More information

Implementing Unit-level Serialization on a New Packaging Line. Mike Salinas Director of Manufacturing Technology M+W U.S., Inc.

Implementing Unit-level Serialization on a New Packaging Line. Mike Salinas Director of Manufacturing Technology M+W U.S., Inc. Implementing Unit-level Serialization on a New Packaging Line Mike Salinas Director of Manufacturing Technology M+W U.S., Inc. April 24, 2013 AGENDA The Counterfeit Drug Problem The Potential Market an

More information

EPCglobal Overview Global EPC/RFID Implementation Overview

EPCglobal Overview Global EPC/RFID Implementation Overview INTERNATIONAL SYMPOSIUM ON AND GDSN 2005 global Overview Global /RFID Implementation Overview Bernie Hogan SVP & CTO Bernie GS1 US Hogan 16 August SVP & CTO 2005 GS1 US Agenda global Overview global Community

More information

BRIDGE Project Pharma Traceability GS1 Healthcare conference, 31 October 2007

BRIDGE Project Pharma Traceability GS1 Healthcare conference, 31 October 2007 Building Radio frequency IDentification solutions for the Global Environment BRIDGE Project Pharma Traceability GS1 Healthcare conference, 31 October 2007 Bridge Objectives To research and develop a set

More information

Manufacturers serialisation challenges with FMD & DR implementation

Manufacturers serialisation challenges with FMD & DR implementation Manufacturers serialisation challenges with FMD & DR implementation Mike Rose Vice President, Supply Chain Visibility, Johnson & Johnson Supply Chain Chairman of EFPIA s Supply Chain WG & FMD Implementation

More information

Global standards to achieve end-to-end traceability. Robert Ballanger Hospital Aulnay-sous-Bois, France

Global standards to achieve end-to-end traceability. Robert Ballanger Hospital Aulnay-sous-Bois, France Global standards to achieve end-to-end traceability Frédérique Fremont Robert Ballanger Hospital Aulnay-sous-Bois, France Topics Background Where we are going Where we are today What this means to you

More information

IMPLEMENTAÇÃO DA DIRETIVA DOS MEDICAMENTOS FALSIFICADOS E ATOS DELEGADOS. Pedro Ferreira ANF

IMPLEMENTAÇÃO DA DIRETIVA DOS MEDICAMENTOS FALSIFICADOS E ATOS DELEGADOS. Pedro Ferreira ANF IMPLEMENTAÇÃO DA DIRETIVA DOS MEDICAMENTOS FALSIFICADOS E ATOS DELEGADOS Pedro Ferreira ANF What are falsified medicines? Growing threat to public health and safety in Europe Counterfeit medicines seized

More information

Guidelines for the Serialisation of Medicinal Products

Guidelines for the Serialisation of Medicinal Products GS1 Standards Guidelines for the Serialisation of Medicinal Products With a Focus on Labelling and Identification Application recommendation Table of Contents Table of figures... 6 1 The role of the PZN

More information

Serialisation. GS1 Standards in Healthcare. Standards Certification Education & Training Publishing Conferences & Exhibits

Serialisation. GS1 Standards in Healthcare. Standards Certification Education & Training Publishing Conferences & Exhibits Serialisation GS1 Standards in Healthcare Standards Certification Education & Training Publishing Conferences & Exhibits Siobhain Duggan Director of Innovation and Healthcare at GS1 Ireland Siobhain is

More information

GLOBAL STANDARDS TECHNICAL IMPLEMENTATION GUIDELINE

GLOBAL STANDARDS TECHNICAL IMPLEMENTATION GUIDELINE USAID GLOBAL HEALTH SUPPLY CHAIN PROGRAM PR O CURE ME NT AND S UPPLY MANAGEMENT GLOBAL STANDARDS TECHNICAL IMPLEMENTATION GUIDELINE Product and Location Identification, Labeling, and Data Exchange Version

More information

SE09. Track & Trace Solutions Jeff Bredemus Werner Electric

SE09. Track & Trace Solutions Jeff Bredemus Werner Electric SE09 Track & Trace Solutions Jeff Bredemus Werner Electric Related Topics SE02 Balluff RFID SE03 Benefits of Image Based Barcode Reading SE08 Vision Solutions for the Food Ind. Solution Area 5 (Motion

More information

Drug distribution in hospitals and barcoding. The needs of traceability of medicines in hospitals

Drug distribution in hospitals and barcoding. The needs of traceability of medicines in hospitals Drug distribution in hospitals and barcoding The needs of traceability of medicines in hospitals Dr. Roberto Frontini, President EAHP president@eahp.eu Conflict of interest Nothing to disclose Dr. Roberto

More information

White Paper. Trust Hi-Speed to show you the way. A Guide to Pharmaceutical Serialization Choosing the Right Equipment Supplier

White Paper. Trust Hi-Speed to show you the way. A Guide to Pharmaceutical Serialization Choosing the Right Equipment Supplier White Paper Trust Hi-Speed to show you the way Choosing the Right Equipment Supplier HS_Serialization White Paper-310_US.indd 1 3/24/2010 9:21:31 AM Contents 1. Introduction 2. The Basics of Serialization

More information

Serialisation and barcoding only against falsified medicines or? Francis Buiter-Rosenberg April 11 th 2013

Serialisation and barcoding only against falsified medicines or? Francis Buiter-Rosenberg April 11 th 2013 Serialisation and barcoding only against falsified medicines or? Francis Buiter-Rosenberg April 11 th 2013 Content Definitions Barcoding and information carrier Benefits for serialisation Benefits for

More information

The FMD Pack Coding, Sharing and Transition

The FMD Pack Coding, Sharing and Transition The FMD Pack Coding, Sharing and Transition Ask the expert Joan Cahill & Grant Courtney April 2017 Introduction Joan Cahill Director, Pfizer Packaging & Delivery Systems Member EFPIA Supply Chain Working

More information

Introduction to GS1 Barcodes. Performance, Packaged

Introduction to GS1 Barcodes. Performance, Packaged Introduction to GS1 Barcodes Performance, Packaged Contents GS1 - The Basics 2 Starting Point - GTIN 3 GTIN Labels for Cases - ITF-14 5 Adding More Data - GS1 128 6 GS1 Application Identifiers 7 Logistics

More information

Recommendations on a harmonised implementation of the EU Falsified Medicines Directive using GS1 standards

Recommendations on a harmonised implementation of the EU Falsified Medicines Directive using GS1 standards Executive Summary The EU Falsified Medicines Directive 2011/62/EU (FMD) and the supplementing Commission Delegated Regulation 2016/161 require the interoperability of product verification repositories

More information

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

Official Journal of the European Union. (Non-legislative acts) REGULATIONS 9.2.2016 L 32/1 II (Non-legislative acts) REGULATIONS COMMISSION DELEGATED REGULATION (EU) 2016/161 of 2 October 2015 supplementing Directive 2001/83/EC of the European Parliament and of the Council by

More information

Exchanging Traceability Data with EPCIS. Senior Manager, Supply Chain Visibility, EPCIS & RFID Bangkok, 31 October 2018 GS1

Exchanging Traceability Data with EPCIS. Senior Manager, Supply Chain Visibility, EPCIS & RFID Bangkok, 31 October 2018 GS1 Exchanging Traceability Data with EPCIS Craig Alan Repec GS1 Healthcare Conference Senior Manager, Supply Chain Visibility, EPCIS & RFID Bangkok, 31 October 2018 GS1 EPCIS: a GS1 Share standard EPCIS CBV

More information

How to start implementing traceability in a country

How to start implementing traceability in a country How to start implementing traceability in a country Ask the expert Grant Courtney April 2016 Introduction Grant Courtney Member of GS1 Healthcare Leadership Team 21 Years experience in Healthcare - GSK

More information

Future in Pharmaceuticals. The countdown to Serialisation and the benefits of implementing GS1 Standards

Future in Pharmaceuticals. The countdown to Serialisation and the benefits of implementing GS1 Standards Future in Pharmaceuticals The countdown to Serialisation and the benefits of implementing GS1 Standards GS1 Ireland Healthcare 26 th February 2014 New McKinsey & Company report on benefits of a single

More information

Product serialization and traceability mandates. kpmg.com

Product serialization and traceability mandates. kpmg.com Product serialization and traceability mandates kpmg.com 1 Product serialization and traceability mandates Increasing threats to patient safety from counterfeited, adulterated, and diverted pharmaceutical

More information

Safety Features Required by the Falsified Medicines Directive 2011/62/EU

Safety Features Required by the Falsified Medicines Directive 2011/62/EU TOPRA Annual Human Medicines Symposium 2017 Safety Features Required by the Falsified Medicines Directive 2011/62/EU Syed Qadri, Global Regulatory Affairs Strategy EU/ROW Jazz Pharmaceuticals Syed.Qadri@jazzpharma.com

More information

Meeting the FDA s Initiative for Protecting. the US Drug Supply

Meeting the FDA s Initiative for Protecting. the US Drug Supply Meeting the FDA s Initiative for Protecting the US Drug Supply Tatsuya Inaba Research Affiliate, MIT Edmund W. Schuster Research Affiliate, MIT Submitted for publication in the American Pharmaceutical

More information

Healthy solutions for the healthcare industry.

Healthy solutions for the healthcare industry. Healthy solutions for the healthcare industry. Vertical Market Healthcare Solutions Photo: thinkstock We take care of the products that take care of people. The reliable delivery of healthcare products

More information

Automated English Translation of Brazil RDC using Google Translate NATIONAL HEALTH SURVEILLANCE AGENCY

Automated English Translation of Brazil RDC using Google Translate NATIONAL HEALTH SURVEILLANCE AGENCY using Google Translate Provided by RxTrace for discussion only. Do not base your compliance activities on this unofficial machine-translation. May 19, 2017 Note that this version of RDC-157 is intended

More information

An industry perspective on medicines barcoding and bedside scanning

An industry perspective on medicines barcoding and bedside scanning An industry perspective on medicines barcoding and bedside scanning Chris Dierickx Manager Business Development - Pfizer Global Supply Puurs Monday the 14 th of October 2013 Content Introduction Pfizer

More information

SERIALIZATION. Counterfeit Medicines: A Worldwide Problem

SERIALIZATION. Counterfeit Medicines: A Worldwide Problem SERIALIZATION Counterfeit Medicines: A Worldwide Problem SERIALIZATION COUNTERFEIT MEDICINES: A WORLDWIDE PROBLEM By Olivier Feraille, Cognex Corporation 10% OF MEDICINES AROUND THE WORLD COULD BE COUNTERFEIT

More information

Building Safer and Smarter Supply Chains. Vish Ganti, IBM

Building Safer and Smarter Supply Chains. Vish Ganti, IBM Building Safer and Smarter Supply Chains Vish Ganti, IBM Supply Chains are fraught with gaping inefficiencies 8-10% of worldwide drug supply is counterfeit Manufacturers carry up to 10% in safety stock

More information

EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update

EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update EU IDMP Taskforce Falsified Medicines Directive and European Medicines Verification System Update 19 th February 2016 EMA London Falsified Medicines February 9 th 2016 Delegated Regulation (EU) 2016/161

More information

Falsified Medicines Directive: Overview from the Irish Medicines Verification Organisation (IMVO) LEONIE CLARKE - 28 TH MARCH HUG

Falsified Medicines Directive: Overview from the Irish Medicines Verification Organisation (IMVO) LEONIE CLARKE - 28 TH MARCH HUG Falsified Medicines Directive: Overview from the Irish Medicines Verification Organisation (IMVO) LEONIE CLARKE - 28 TH MARCH 2017 - HUG EU requirements * for repositories of unique identifiers Every MS

More information

APPLICATION WHITE PAPER

APPLICATION WHITE PAPER New Pharmaceutical Marking Guidelines and Opportunities Tips, techniques and technologies for implementing unit-of-use bar code, anti-counterfeiting and RFID labeling to improve patient safety, satisfy

More information

HUG. HUG Business Case. Princeton, NJ Ed Dzwill J&J Global Pharm Sourcing Group

HUG. HUG Business Case. Princeton, NJ Ed Dzwill J&J Global Pharm Sourcing Group HUG HUG Business Case Princeton, NJ Ed Dzwill J&J Global Pharm Sourcing Group Business Case - Overview Objective: The Case for Global Standards: Creating the Business Case for Global Data Standards in

More information

Healthcare Sector. - Upcoming legislations - GS1 standards. Ann Luyckx Healthcare Manager. Phi Data Event 2018

Healthcare Sector. - Upcoming legislations - GS1 standards. Ann Luyckx Healthcare Manager. Phi Data Event 2018 Healthcare Sector - Upcoming legislations - GS1 standards Ann Luyckx Healthcare Manager Phi Data Event 2018 Anti-trust GS1 Belgium & Luxembourg will not enter into any discussion, activity or conduct that

More information

Seminars of Software and Services for the Information Society. Introduction to RFId Radio Frequency Identification

Seminars of Software and Services for the Information Society. Introduction to RFId Radio Frequency Identification DIPARTIMENTO DI INGEGNERIA INFORMATICA AUTOMATICA E GESTIONALE ANTONIO RUBERTI Master of Science in Engineering in Computer Science (MSE-CS) Seminars in Software and Services for the Information Society

More information

Manufacturing Intelligence: Serialization to Improve Processes. Presented By Jean Pierre Allard Serialization Product Manager Optel Vision

Manufacturing Intelligence: Serialization to Improve Processes. Presented By Jean Pierre Allard Serialization Product Manager Optel Vision Manufacturing Intelligence: Serialization to Improve Processes Presented By Jean Pierre Allard Serialization Product Manager Optel Vision INTRODUCTION Agenda Standards Overview General Solution Architecture

More information

Automatic Tracking and Tracing Solutions along supply chain

Automatic Tracking and Tracing Solutions along supply chain Automatic Tracking and Tracing Solutions along supply chain Dr. Zubin Varghese Siemens Corporate Research & Technologies India Bangalore 1 A Quick Question As a customer, are you sure that you are buying

More information

Marking, coding and tracing of tobacco products. Leuven, 4 September 2008 Luk Joossens

Marking, coding and tracing of tobacco products. Leuven, 4 September 2008 Luk Joossens Marking, coding and tracing of tobacco products Leuven, 4 September 2008 Luk Joossens Cigarette packaging A pack contains generally 20 cigarettes A carton contains generally 10 packs or 200 cigarettes

More information

Welcome to our 29 th Global GS1 Healthcare Conference. Follow us on Twitter and tweet about the #GS1HCuae

Welcome to our 29 th Global GS1 Healthcare Conference. Follow us on Twitter and tweet about the #GS1HCuae Welcome to our 29 th Global GS1 Healthcare Conference Follow us on Twitter and tweet about the conference! @GS1Healthcare #GS1HCuae Welcome to the conference 29 th Global GS1 Healthcare Conference Dubai,

More information

Corporate Presentation & Offer for SAP ATTP December 2015

Corporate Presentation & Offer for SAP ATTP December 2015 Corporate Presentation & Offer for SAP ATTP December 2015 Page : 1 Page : 2 Content Our Vision Our Company Business Challenges SAP Advanced Track and Trace for Pharmaceuticals (ATTP) Our Offer Our Vision

More information

The Danish Generic Medicines Industry Association (IGL)

The Danish Generic Medicines Industry Association (IGL) The Danish Generic Medicines Industry Association (IGL) comments on the concept paper on the delegated act for a unique identifier for medicinal products for human use, and its verification. The Danish

More information

Serialisation Snapshot: The Current State of Readiness

Serialisation Snapshot: The Current State of Readiness Serialisation Snapshot: The Current State of Readiness Polling Data from NEXUS 17 At NEXUS 17 in Barcelona, nearly 200 people from over 120 companies met to discuss how they re preparing for the challenge

More information

EPC Primer. Erik Sundermann HUG Meeting - Paris 20th Sept 2006

EPC Primer. Erik Sundermann HUG Meeting - Paris 20th Sept 2006 EPC Primer Erik Sundermann HUG Meeting - Paris 20th Sept 2006 Agenda The Fundamentals of RFID The Internet of Things The EPCglobal Organization EPCglobal Network Standards Physical Object Exchange Standards

More information

GS1 Healthcare - Discussion paper on multi-market packs for pharmaceutical products

GS1 Healthcare - Discussion paper on multi-market packs for pharmaceutical products Purpose This GS1 Healthcare paper has been written to help demonstrate ways in which GS1 bar codes can be used to minimise the need for multiple bar codes to appear on product packaging while still enabling

More information

GUIDANCE ON IMPLEMENTATION OF IDENTIFICATION AND BARCODING OF MEDICINAL PRODUCTS FOR HUMAN USE

GUIDANCE ON IMPLEMENTATION OF IDENTIFICATION AND BARCODING OF MEDICINAL PRODUCTS FOR HUMAN USE T.C. TURKISH MINISTRY OF HEALTH G.D. OF PHARMACEUTICALS AND PHARMACIES GUIDANCE ON IMPLEMENTATION OF IDENTIFICATION AND BARCODING OF MEDICINAL PRODUCTS FOR HUMAN USE Version 1.4 Ankara, 2011 Index Index...

More information

The Past, the Present and the Future that GS1 Healthcare Standards will deliver for the African Continent

The Past, the Present and the Future that GS1 Healthcare Standards will deliver for the African Continent The Past, the Present and the Future that GS1 Healthcare Standards will deliver for the African Continent African GS1 Healthcare Conference, Addis Ababa, Ethiopia Tunde Odunlami, CEO GS1 Nigeria 8 May,

More information

Being Prepared for Track and Trace: DSCSA 101

Being Prepared for Track and Trace: DSCSA 101 Being Prepared for Track and Trace: DSCSA 101 Susanne Somerville, Founder The LinkLab Eric Garvin, Founder, The LinkLab Brian Daleiden, VP Industry Marketing and Co-Founder, TraceLink Objective of Today

More information

KyoungjaLee. Korea Pharmaceutical Information Service (KPIS), Korea

KyoungjaLee. Korea Pharmaceutical Information Service (KPIS), Korea KyoungjaLee Korea Pharmaceutical Information Service (KPIS), Korea Pharmaceutical Serialization in Korea Pharmaceutical serialization policy & national traceability system KyoungjaLee, General Director

More information